Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Quitkin

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
The Journal of Clinical Psychiatry|July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapyJ Zajecka, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry|August 11, 2000
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depressionP J McGrath, J W Stewart, E Petkova, et al.
The American Journal of Psychiatry|February 1, 1991
Heterogeneity of clinical response during placebo treatmentF M Quitkin, J G Rabkin, J W Stewart, et al.
Archives of General Psychiatry|September 1, 1989
Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depressionF M Quitkin, P J McGrath, J W Stewart, et al.
Psychopharmacology Bulletin|January 1, 1989
Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depressionB Parsons, F M Quitkin, P J McGrath, et al.
The American Journal of Psychiatry|February 1, 1991
Different types of placebo response in patients receiving antidepressantsF M Quitkin, P J McGrath, J G Rabkin, et al.
Archives of General Psychiatry|October 1, 1990
Atypical depression, panic attacks, and response to imipramine and phenelzine. A replicationF M Quitkin, P J McGrath, J W Stewart, et al.
Archives of General Psychiatry|July 1, 1984
The tyramine challenge test as a marker for melancholiaW M Harrison, T B Cooper, J W Stewart, et al.
Archives of General Psychiatry|April 1, 1991
Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover designF M Quitkin, W Harrison, J W Stewart, et al.
Biological Psychiatry|November 27, 2001
Strengthening clinical effectiveness trials: equipoise-stratified randomizationP W Lavori, A J Rush, S R Wisniewski, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Clinical Psychiatry|July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapyJ Zajecka, J D Amsterdam, F M Quitkin, et al.
The Journal of Clinical Psychiatry|August 11, 2000
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depressionP J McGrath, J W Stewart, E Petkova, et al.
The American Journal of Psychiatry|February 1, 1991
Heterogeneity of clinical response during placebo treatmentF M Quitkin, J G Rabkin, J W Stewart, et al.
Archives of General Psychiatry|September 1, 1989
Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depressionF M Quitkin, P J McGrath, J W Stewart, et al.
Psychopharmacology Bulletin|January 1, 1989
Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depressionB Parsons, F M Quitkin, P J McGrath, et al.
The American Journal of Psychiatry|February 1, 1991
Different types of placebo response in patients receiving antidepressantsF M Quitkin, P J McGrath, J G Rabkin, et al.
Archives of General Psychiatry|October 1, 1990
Atypical depression, panic attacks, and response to imipramine and phenelzine. A replicationF M Quitkin, P J McGrath, J W Stewart, et al.
Archives of General Psychiatry|July 1, 1984
The tyramine challenge test as a marker for melancholiaW M Harrison, T B Cooper, J W Stewart, et al.
Archives of General Psychiatry|April 1, 1991
Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover designF M Quitkin, W Harrison, J W Stewart, et al.
Biological Psychiatry|November 27, 2001
Strengthening clinical effectiveness trials: equipoise-stratified randomizationP W Lavori, A J Rush, S R Wisniewski, et al.
Pageof 16